CG Oncology (CGON) said Wednesday that it has filed a registration statement for a proposed underwritten public offering of 7.3 million shares of its common stock.
The company said it plans to grant the underwriters a 30-day option to buy up to an additional 1.2 million shares of its common stock.
The company added that an existing stockholder also plans to sell 700,000 shares of common stock in the proposed offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.